Helena Strigård appointed as new CEO of rapidly expanding NorthX Biologics
September 20, 2022 01:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The Board of NorthX Biologics ("NorthX") has appointed Helena Strigård as the new CEO. She joins NorthX from her role as Director General for the...
Helena Strigård ny vd för snabbt expanderande NorthX Biologics
September 20, 2022 01:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, Sept. 20, 2022 (GLOBE NEWSWIRE) -- NorthX Biologics (“NorthX”) styrelse har utsett Helena Strigård till ny vd. Hon kommer närmast från rollen som vd för branschorganisationen...
NorthX Biologics expanderar till cellterapi: Partnerskap med Alder Therapeutics och ny tillverkningsanläggning på Karolinska campus i Stockholm
June 21, 2022 02:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- NorthX Biologics (“NorthX”) har meddelat att de utöver att utöka sin tillverkning av cellterapier vid sin befintliga GMP-anläggning, även...
NorthX Biologics expands to Cell Therapy: Partnership with Alder Therapeutics and new manufacturing site on Karolinska campus
June 21, 2022 02:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Sweden-based NorthX Biologics (“NorthX”) is expanding into cell therapy manufacturing at its existing GMP-facility, as well as in premises at the...
NorthX Biologics utser branschveteraner till sin styrelse
June 14, 2022 02:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sverige, June 14, 2022 (GLOBE NEWSWIRE) -- Sverigebaserade NorthX Biologics ("NorthX"), som specialiserar sig på processutveckling och GMP-tillverkning av avancerade biologiska läkemedel,...
NorthX Biologics appoints industry veterans to its board of directors
June 14, 2022 02:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, June 14, 2022 (GLOBE NEWSWIRE) -- Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and GMP manufacture of advanced biological drugs, has announced the...
Flerie Invest AB leads $52m acquisition of Swedish Biopharma Facility from Charles River
October 15, 2021 01:00 ET
|
FLERIE INVEST AB
STOCKHOLM, Sweden, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Flerie Invest, a biotech and pharma investment firm with offices in Stockholm and London, led a syndicate of investors in the $52m acquisition of...